Intensity Therapeutics, Inc. (“Intensity” or the “Company”) (Nasdaq: INTS), a clinical-stage biotechnology company focused on the discovery…
Month: June 2023
Dialysis Patient Citizens Statement on New CMS Rule That Would Harm Patient Access to Care
Dialysis Patient Citizens (DPC), the nation’s largest dialysis patient advocacy organization, released the following statement regarding…
World Neurotech Devices Market Report 2023-2033: Increasing Awareness and Funding Bodes well for the Multi-Billion Dollar Market
The “Neurotech Devices Market Report 2023-2033” report has been added to ResearchAndMarkets.com’s offering. The market will surpass US$13.10 billion in 2023 Growing…
Global Patient Warming Devices Strategic Business Report 2023: Uptrend in Healthcare Spending to Result in Improved Opportunities
The “Patient Warming Devices: Global Strategic Business Report” report has been added to ResearchAndMarkets.com’s offering. The global market for Patient…
AWAK Technologies and Singapore General Hospital launch pre-pivotal clinical trial of wearable peritoneal dialysis device
AWAK Technologies (AWAK) and Singapore General Hospital (SGH) announce the launch of a pre-pivotal clinical trial…
Lucile Packard Children’s Hospital Stanford Continues to Rank Among Top Children’s Hospitals in the Nation
Lucile Packard Children’s Hospital Stanford has once again been named the top children’s hospital in Northern California and is ranked…
U.S. News & World Report Names MemorialCare Miller Children’s & Women’s Hospital Long Beach Among Best in Nation for Pediatric Pulmonology and Lung Surgery
MemorialCare Miller Children’s & Women’s Hospital Long Beach has been nationally ranked #40 as a 2023-2024 Best…
CymaBay Therapeutics Presents Data Showing Seladelpar Treatment in Primary Biliary Cholangitis (PBC) Correlates with Alleviation of Self-Reported Pruritus and Reduction in Serum IL-31 Levels
CymaBay Therapeutics, Inc. (NASDAQ: CBAY), a clinical-stage biopharmaceutical company focused on developing therapies for liver and other…
EQT Private Equity to sell Ellab, following transformation into a leading validation & monitoring provider for the Biotech and Pharmaceutical industries
EQT is pleased to announce that EQT Mid Market Europe (“EQT Private Equity”), together with its…
UNION therapeutics announces positive topline results from the OSIRIS investigator-initiated proof-of-concept study of oral orismilast in patients with hidradenitis suppurativa
UNION therapeutics A/S (UNION), a privately-held, clinical stage, pharmaceutical development company focused on immunology and infectious…